Long-Term Failure Patterns and Survival in a Randomized Dose-Escalation Trial for Prostate Cancer. Who Dies of Disease?

Article ID	Journal	Published Year	Pages	File Type
8230307	International Journal of Radiation OncologyBiologyPhysics	2011	8 Pages	PDF

Abstract

Moderate dose escalation (78 Gy) decreases biochemical and clinical failure as well as prostate cancer death in patients with pretreatment PSA >10 ng/mL or high-risk disease.

Keywords

Dose escalation Failure patterns Survival Radiotherapy Prostate cancer

Related Topics

Physical Sciences and Engineering Physics and Astronomy Radiation

Preview

Long-Term Failure Patterns and Survival in a Randomized Dose-Escalation Trial for Prostate Cancer. Who Dies of Disease?

Authors

Deborah A. M.D., Lawrence B. Levy, M. Rex M.D. Ph.D., Andrew K. M.D., M.P.H., Seungtaek M.D., Steven M.D., Alan M.D., Ph.D.,